Close Menu
Home » GenomeQuest Snags Emory as Latest Lab to Use GQ-Dx for NGS Diagnostics; Eyes Dx Partnerships

GenomeQuest Snags Emory as Latest Lab to Use GQ-Dx for NGS Diagnostics; Eyes Dx Partnerships

Feb 24, 2012
Premium

By Bernadette Toner

GenomeQuest this week said that the Emory Genetics Laboratory is using its GQ-Dx software to support a suite of sequencing-based diagnostic tests it offers through its CLIA-certified facility.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Harvard Prof Charged

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

But What About That Preserved Frog Smell?

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Level of Transparency

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

PNAS Papers Describe Amish De Novo Mutation Decrease, RNA Sequencing Method, Precision Med Results

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

What's Popular?

In Informatics

  1. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

  2. Precision Health Company ixLayer Introduces Platform to Streamline Genetic Test Delivery

    Premium

  3. Noscendo, University Hospital Bonn Partner on Pathogen-Detection Platform Development

  4. Quest Diagnostics Acquires Blueprint Genetics

  5. Predictive Oncology to Acquire Quantitative Medicine

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.